Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Erosive lichen sclerosus is a distinct subtype with specific skin features, and treatment led to complete resolution in half of the cases.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

The 2012 criteria are better for diagnosing atypical lupus cases.

Two sisters with lipoedematous scalp suggest a genetic influence in the condition.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

The modified hair loss classification is more detailed but less user-friendly.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

GLP-1RA therapy may increase the risk of hair loss.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Removing the liver tumor improved the patient's skin condition and hair growth.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Men with androgenetic alopecia may have more severe dry eye and meibomian gland dysfunction.

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

New ginseng compounds may help treat degenerative diseases.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

The study developed methods to measure biomarkers in mice and found differences in hormone levels linked to gut microbiota diversity and stress response.

Higher antigliadin antibody levels are linked to alopecia areata severity.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.